Effects of dignity therapy on terminally ill patients: a systematic review by Donato, Suzana Cristina Teixeira et al.
1011
Donato SCT, Matuoka JY, Yamashita CC, Salvetti MG
www.ee.usp.br/reeusp Rev Esc Enferm USP · 2016;50(6):1011-1021
* Extracted from the concluding residency work 
“Efeitos da terapia da dignidade para pacientes em 
fase final de vida: revisão sistemática”, Programa 
de Residência em Enfermagem na Saúde do 
Adulto e Idoso, Escola de Enfermagem/Hospital 
Universitário, Universidade de São Paulo, 2016.
1 Universidade de São Paulo, Escola de 
Enfermagem, São Paulo, SP, Brazil.
2 Universidade de São Paulo, Escola de 
Enfermagem, Programa de Pós-Graduação 
em Saúde do Adulto, São Paulo, SP, Brazil.
3 Instituto do Câncer do Estado 
de São Paulo, Serviço de Cuidados 
Paliativos, São Paulo, SP, Brazil.
4 Universidade de São Paulo, Escola de 
Enfermagem, Departamento de Enfermagem 
Médico-Cirúrgica, São Paulo, SP, Brazil.
ABSTRACT
Objective: Analyzing the evidence of the effects of dignity therapy on terminally ill 
patients. Method: A Systematic review of the literature conducted using the search 
strategy in six databases. Inclusion criteria were primary studies, excluding literature 
reviews (systematic or not) and conceptual articles. Results: Ten articles were analyzed 
regarding method, results and evidence level. Dignity therapy improved the sense of 
meaning and purpose, will to live, utility, quality of life, dignity and family appreciation 
in studies with a higher level of evidence. The effects are not well established in relation 
to depression, anxiety, spirituality and physical symptoms. Conclusion: Studies with a 
moderate to high level of evidence have shown increased sense of dignity, will to live 
and sense of purpose. Further studies should be developed to increase knowledge about 
dignity therapy.
DESCRIPTORS
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INTRODUCTION
The term dignity was defined by the philosopher 
Immanuel Kant in the study Groundwork of the Metaphysics 
of Morals, where he dissected the concept of dignity from 
the realm of religiosity by bringing it into the political and 
social realm, defining it as an irreplaceable value that coats 
all people, devoid of religious value(1). In this respect, it is an 
intrinsic quality of human beings, since they have autonomy 
in exercising practical reasoning as each individual has dis-
tinct individual and indispensable personalities. The author 
claims that autonomy and dignity are distinct concepts, 
however, inseparable in the exercise of practical reason, and 
concluding that for this reason, only human beings can be 
coated with dignity(1).
Many authors have discussed the term dignity through-
out history; however, in a generic way, without portraying 
aspects of terminally ill patients. In the middle of 1991, a 
year in which the study Euthanasia and other medical decisions 
concerning the end of life(2) was developed, the term dignity 
began to be related to some issues of patients with incur-
able diseases. In this study, loss of dignity appeared as the 
motivating factor for the choice of euthanasia or assisted 
suicide in 57% of patients who had opted for this outcome(2). 
For the first time, loss of dignity was related to important 
decisions at the end of life, demonstrating the need to bring 
the theme of dignity into the context of terminality.
In 2002, a study investigated variables that interfered 
with the dignity of terminally ill patients and showed that 
54% of the patients had a strong or intact sense of dignity, 
46% reported that they had occasional and slight concerns 
about their dignity, and 7.5% reported that a loss of dignity 
was a serious problem in their lives, often associated with 
feelings of degradation and shame(3).
The group of patients with threatened dignity presented 
lower quality of life and satisfaction, being associated with 
depression, anxiety, hopelessness and a greater desire for 
anticipation of death(3). Issues of deterioration of appearance, 
the feeling of being a burden, the need to be assisted during 
activities of daily living were related to loss of personal com-
petence, autonomy and loss of personal identity, impacting 
on the sense of dignity(3). Study participants were being fol-
lowed by palliative care programs of excellence, which may 
have directly influenced the smaller number of patients who 
reported a problem related to aspects of dignity.
Another research has shown how patients diagnosed 
with advanced cancer conceived the term dignity, providing 
the basis for developing a conceptual model of dignity. Issues 
that could increase or decrease patients’ sense of dignity were: 
the behaviors of family members, friends and health pro-
fessionals, aspects that provided meaning to life, essential 
activities, their own philosophies and feelings such as pride, 
self-respect, quality of life, well-being, hope and self-esteem. 
At the end of the study the authors proposed a conceptual 
model of dignity, arranged in three fundamental categories: 
concerns related to the disease (physical and psychological 
symptoms), personal resources of dignity (psychological and/
or spiritual factors that influence the sense of dignity) and 
social resources of dignity (social context, encompassing 
positive aspects, challenges and suffering)(4).
The model was proposed with the objective of defining 
physical, spiritual and psychosocial issues of terminally ill 
patients with some degree of impairment of dignity and, 
thus, improving the quality of life of these patients. From 
this conceptual model, Dignity Therapy (DT) was created by 
Chochinov in 2005, a psychotherapeutic intervention devel-
oped to give meaning to questions fostering psychosocial and 
existential anguish/suffering, with a brief and individualized 
approach that allows patients to discuss the most important 
individual issues for constructing a legacy document that can 
be remembered after imminent death(5).
As the main contribution of therapy is the building of 
a legacy, patients are guided by a therapist (a trained health 
professional) to raise important questions – wishes, memories 
and/or unfinished business – audio recorded by the profes-
sional, who subsequently transcribes and edits them in the 
form of a document, and according to the patient’s choice it 
can be delivered during their life or after their death to rela-
tives or other loved ones(6). The palliative care team can also 
make use of this material to better understand end-of-life 
issues and provide care focused on the specifics of each patient.
Through these studies, we have hypothesized that loss of 
dignity may diminish as terminally ill patients are cared for 
in a comprehensive environment with quality support that 
provides holistic care associated to a symptomatic effective 
treatment; considering that the preservation of dignity is 
related to the care provided, the sensitivity of health profes-
sionals and caregivers, and the intensity of care(6).
According to the World Health Organization, palliative 
care strategy should be developed by a multiprofessional 
team that focuses attention not on the disease to be cured/
controlled, but on the patient/person, who are understood 
as active biographical beings, with the right to information 
and full autonomy for decisions regarding their treatment. 
The care must be individualized to the patient and their 
family, in order to obtain control of all symptoms and to 
prevent suffering(7).
Data from the National Cancer Institute show that 596 
thousand new cases of cancer are estimated in Brazil in 
2016(8). According to IBGE (Instituto Brasileiro de Geografia 
e Estatística), in 2050 there will be more older adults than 
children under 15 years of age. In 2012, the world population 
had 810 million people aged 60 and over, making up 11.5% 
of the global population. Projections indicate that in 2050 
older adults will make up 22% of the global population(9). 
Furthermore, according to a study published in 2014, the 
most frequent causes of death in Brazil are cardiovascular 
diseases (30.4%), neoplasias (16.4%), respiratory diseases 
(6%) and diabetes (5.3%)(10). Thus, many patients need or will 
need a palliative approach and, since the WHO advocates 
that all issues of care should be addressed, including spiritual, 
psychosocial and family (issues), therapies that address these 
aspects may be significant in palliative care(7).
Considering the prevalence of terminally ill patients and 
that they have problems regarding dignity and its physical, 
emotional and psychosocial consequences, the objective of 
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this study is to analyze evidence on the effects of Dignity 
Therapy on terminally ill patients. To meet this goal, the 
following research question was formulated: What are the 
physical, spiritual, and psychosocial effects of dignity therapy for 
terminally ill patients?
METHOD
This is a systematic review of the literature following 
the recommendations of the Preferred Reporting Items for 
Systematic Reviews and Meta-Analysis (PRISMA) guide-
line(11-13). The PICO strategy was used to guide the research, 
in which P refers to the patient (terminally ill patients), I 
to the intervention (dignity therapy), C to the compari-
son (comparison with other interventions, as a search strat-
egy was not used), O to the outcomes (physical, spiritual and 
psychosocial effects of dignity therapy). The searches were 
conducted from August to December 2015(11-13).
Searches were carried out in six databases, namely: 
CINAHL, COCHRANE, LILACS, PubMed, SCOPUS, 
and WEB OF SCIENCE, in addition to articles found 
through manual searching in other sources such as free 
searches on Google Scholar and those found in the refer-
ences of the analyzed articles, providing they met the inclu-
sion criteria. The descriptors used in the search were selected 
through DeCS (descriptors in health sciences), MeSH 
(Medical Subject Headings) and CINAHL (Cumulative 
Index to Nursing and Allied Health Literature).
Chart 1 shows how the descriptors were used for each 
element of the PICO acronym.
Chart 1 – Descriptors for each element according to the PICO 
strategy – São Paulo, 2015/2016.
CONTROLLED DESCRIPTORS UNCONTROLLED DESCRIPTORS
P
Palliative care, terminally ill, 
terminal care, hospice care, 
hospice and palliative care nursing.
CINAHL – “hospice and palliative 
nursing”.
Palliative Care, 
Terminally Ill, terminal 
care, hospice care, 
hospice and palliative 
care nursing.
I Living will, psychotherapy, brief psychotherapy.
Dignity therapy, living 
will, psychotherapy, brief 
psychotherapy.
C – –
O Quality of life. Quality of life.
To broaden the reach to studies of interest, the search 
strategy included controlled and uncontrolled descriptors 
combined with each other, as described below: “Palliative 
Care” OR “Hospice Care” OR “Hospice and Palliative Care 
Nursing” OR “Terminal Care” OR “Terminally Ill” AND 
“Living Wills” OR “Psychotherapy” OR “Psychotherapy, 
Brief ” OR “dignity therapy” AND “Quality of Life”.
The level of evidence was classified according to the 
GRADE system (Grading of Recommendations Assessment, 
Development and Evaluation), which covers a number of 
recommendations that guide the process of assessing the 
quality of evidence from studies included in systematic 
reviews. The scores range from 1 to 4, according to the level 
of evidence: 1 – very low, 2 – low, 3 – moderate and 4 – high. 
Randomized controlled trials have a higher level of evidence 
and non-randomized studies receive lower scores. Factors 
that may decrease the quality of evidence are: bias risk (I), 
inconsistency (II), indirect evidence (III), imprecision (IV) 
and publication bias (V); and factors that may increase the 
level of evidence are related to magnitude of effect (effect 
size (VI), dose-response gradient (VII) and possible residual 
confusion (VIII)(14).
Randomized and controlled clinical trials have a thera-
peutic focus and provide the best scientific evidence, since 
randomization of subjects for allocation in study groups 
is the best way to make groups similar and comparable, 
reducing risk of bias. In quasi-experimental studies, how-
ever, there is no group comparison and the same subjects 
are evaluated before and after the experiment. Although 
quasi-experimental studies also bring relevant information, 
the evidence produced is more fragile because the patient is 
their only control(12).
According to the GRADE System guidelines(14), ran-
domized clinical trials have high levels of evidence (4 points) 
and they can gain or lose points according to the analy-
sis of the items that are recommended in the trials. Non-
randomized studies begin the analysis with a lower level 
of evidence and can gain or lose points according to an 
evaluation of the methodological quality, for example, non-
randomized studies may increase points if they present a 
large magnitude of effect(14). Thus, a high level of evidence 
means that the effect estimate and the true effect are close; 
in the case of moderate evidence, the true effect is likely to 
be close to the effect estimate, but there is a possibility of it 
being substantially different. In low and very low evidence, 
we have limited and little confidence in the estimation of 
the effect, respectively.
The inclusion criteria used were: primary studies that 
addressed the effects of dignity therapy, with a sample 
composed of adults (18 years of age or older). Articles in 
Portuguese, English or Spanish. Exclusion criteria were: 
literature reviews (systematic or not) and conceptual studies. 
The studies that met the inclusion criteria and answered the 
research question were selected for analysis in their entirety.
RESULTS
The searches resulted in retrieval of 1,111 articles and 
12 other articles were found by a manual search from other 
sources. Of these, 979 were excluded by the title for not 
being related to the subject, and 54 duplicates were removed. 
After reading the abstracts, 56 were selected for full readings; 
19 were excluded because they were not directly related to 
the subject; 25 more were excluded because they were con-
ceptual studies and two articles were excluded because they 
addressed the effects of DT in patients with motor neuron 
disease (MND). The objective of the review was to analyze 
the effects of DT on terminally ill patients and MND is not 
a terminal illness, so the studies were excluded, although 
they represented innovative therapy application originally 
proposed by Chochinov(4-5). Finally, 10 studies remained, 
which were included in the final analysis of the review. The 
study selection process is presented via flowchart in Figure 1, 
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and this is an adaptation of the self-fill out model proposed 
by the PRISMA guideline(11-12).
The articles analyzed were published between 2005 and 
2015. Of the studies selected, 80% were found in PubMed, 
10% in SCOPUS and 10% in COCHRANE. No stud-
ies were selected in the searches performed in LILACS, 
CINAHL, WEB OF SCIENCE or through a man-
ual search.
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Figure 1 – Flowchart of selection of the articles of the Systematic Review, according to PRISMA(11-12) – São Paulo, 2015/2016.
The characterization of the studies included in the review is 
summarized in Chart 2, and is organized according to author/
year/place, type of study, objectives, sample, and results. The 
studies were grouped according to the patients’ profile and 
are discussed below. The studies included for analysis in the 
review were grouped according to the location in which the 
patients were approached for the application of the interven-
tions, and were listed from A1 to A10 for better organization 
of the results. In other words, group 1 gathered studies in 
which the patients were hospitalized (A1 and A2)(6,15), group 2 
studies include outpatients (A3 to A7)(16-20), and group 3 stud-
ies included inpatients and outpatients (A8 to A10)(5,21-22).
Chart 2 – Characterization of articles included in the review – São Paulo, 2015.
Author/
year/place 
of study
Type of 
study Goal Sample Results
Group 1 – Patients in palliative care with advanced/terminal disease in hospitalization unit
A1
Julião et al., 
2013 – 
Portugal(6)
Randomized 
Clinical Trial
Determine the 
effects of DT on 
the symptoms of 
depression and 
anxiety in patients 
with high level of 
suffering.
n = 60 terminal patients 
with life expectancy ≤ 
6 months. Submitted 
to DT associated with 
palliative care (n = 29) 
and palliative care 
(n = 31);
95% cancer and 5% 
with non-malignant 
terminal conditions.
Patients undergoing DT showed a decrease in 
depression score on the fourth day (p = 0.001), 
maintained on the 15th day (p = 0.022), but not on 
the 30th day (p = 0.097). Lower indices of anxiety 
in all assessment periods (4th day – p = 0.005, 15th 
day – p = 0.006, 30th day – p = 0.054). Showed 
improvements regarding anxiety and depression, 
even in patients with high levels of suffering at the 
beginning. As an improvement in depression is not 
maintained until the 30th day, it is hypothesized that 
a single DT session may be insufficient.
continued...
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Author/
year/place 
of study
Type of 
study Goal Sample Results
A2
Julião et al., 
2014 – 
Portugal(15)
Randomized 
Clinical Trial
Evaluate the 
effectiveness of DT 
on depression and 
anxiety scores of 
patients in palliative 
care.
n = 80 patients in 
palliative care with life 
expectancy ≤ 6 months. 
Submitted to DT 
(n = 39) and palliative 
care (n = 41);
92.5% cancer and 7.5% 
with non-malignant 
terminal conditions.
Patients undergoing DT showed a decrease in 
depression score in all periods of the evaluation 
in relation to the control group (4th day – p < 
0.0001, 15th day – p = 0.010, 30th day – p = 0.043). 
There was a significant decrease in anxiety for all 
periods (4th day – p < 0.0001, 15th day – p = 0.001, 
30th day – p = 0.003). DT showed improvements 
regarding anxiety and depression, even in patients 
with high levels of suffering at the beginning of the 
study. The improvements also showed a sustained 
effect (until the 30th day).
Group 2 – Outpatients/patients in palliative care with advanced/terminal disease
A3
Hall et al., 
2011 – 
England(16)
Randomized 
Clinical Trial
Assess the feasibility, 
acceptability and 
potential effectiveness 
of dignity therapy 
in reducing 
psychological and 
spiritual suffering of 
elderly people.
n = 60 elderly people 
in nursing homes. 
Submitted to palliative 
care (n = 29) and DT 
(n = 31);
With oncological 
diseases and not at an 
advanced oncological 
terminal stage (with 
an average survival 
of 6 months in the 
intervention group).
There were no significant differences in the potential 
measures of effectiveness between interventions. The 
DT presented small effects in relation to depression 
and quality of life 1 week after the intervention. 
Acceptability: the variables make life more meaningful 
and serve as an aid to the families, showing significant 
improvement (p = 0.04 and p = 0.02, respectively) 
on the first assessment, after 8 weeks only family 
support remained significant (p = 0.01). The DT was 
higher relative to the size of the effect in the first 
and second reviews, utility (0.38-0.55), made life 
more meaningful (0.58-0.25), increased the sense of 
purpose (0.27-0.53), decreased suffering (0.29-0.34), 
increased the will to live (0.46-0.39), helped or would 
help the family (0.66-0.85). The document/legacy took 
longer to be generated (about 1-5 visits).
A4
Johns et al., 
2013 – 
USA(17)
Quasi-
experimental 
Study
Evaluate the feasibility 
of providing DT.
n = 10 patients with 
metastatic cancer; 100% 
caucasian women with 
stage IV metastatic 
cancer (without 
information on survival 
time).
Patients reported that DT was useful to them and 
to their families; it increased their meaning of life, 
their sense of dignity and decreased suffering (75%). 
With 100% satisfaction. Families and patients 
considered the document/legacy very useful. The 
levels of depression and satisfaction with quality of 
life worsened. The transcripts of the document were 
longer than other studies.
A5
Vergo et al., 
2014 – 
USA(18)
Quasi-
experimental 
Study
Evaluate the feasibility 
of DT in patients with 
colorectal cancer and 
the changes in the 
acceptance of death, 
suffering, symptoms, 
quality of life, 
tranquility, and goals 
of care at the end of 
life and the treatment 
options before and 
after treatment with 
DT for each patient.
n = 9 patients with 
colorectal cancer who 
underwent palliative 
chemotherapy;
100% with stage IV 
metastatic cancer 
(without survival time 
information).
Feasibility of DT: 100% satisfaction, 88% reported 
usefulness of therapy and an increased sense of 
purpose, 78% which increased sense of dignity 
and purpose, 67% which increased the will to live. 
Physical symptoms: appetite improvement after the 
DT. Emotional symptoms: no changes presented. 
Clinical outcomes: increased acceptance of death 
(57% post-DT), choice of care and treatments that 
would not prolong life (58% post-DT).
A6
Rudilla 
et al., 
2014 – 
Spain(19)
Randomized 
Clinical Trial
Identify and quantify 
the significant 
differences in terms 
of emotional distress, 
quality of life and 
preservation of 
dignity after treatment 
with dignity therapy 
(DT) and counseling 
therapy.
n = 30 terminal patients 
in hospice care with 
advanced stage cancer;
Submitted to DT 
(n = 15) and Therapeutic 
counseling (TC) (n = 15);
Served at home. There is 
no specification of the 
survival time.
In the comparison between the two therapies, there 
were no statistically significant differences. Both 
therapies were statistically significant for: decreasing 
suffering (DT p<0.001 and TC p = 0.001), increasing 
of quality of life (DT p = 0.000 and TC p = 0.009), 
decreasing existential suffering (DT p = 0.003 and 
TC p = 0.000).
A7
Rudilla 
et al., 
2015 – 
Spain(20)
Controlled 
Trial
Examine and 
compare the effects 
of dignity therapy 
(DT) and advice on 
meeting the needs of 
the patient.
n = 70 patients in 
palliative care home 
service with advanced 
disease. Submitted to 
Therapeutic counseling 
(n = 35) and DT 
(n = 35);
Oncological and non-
oncological diseases 
(there is no specification 
of survival time).
In the pre-and post-intervention measures for DT, 
there were statistically significant differences in 
symptoms of pain, existential suffering, dependency, 
peace of mind, social support, intrapersonal, 
interpersonal and transpersonal spirituality, 
reliable support and affective support (p < 0.001), 
anxiety, depression (p = 0.001) and quality of life 
(p = 0.011). There were no significant differences 
with regard to resilience (p = 0.058). Counseling 
Therapy was superior to the DT regarding anxiety 
(p = 0.022). Also, analyzed in isolation obtained 
good results regarding resilience (p = 0.005).
...continuation
continued...
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An analysis of the selected study designs showed: five ran-
domized controlled trials (50%), three with a moderate level 
of evidence and two with a high level of evidence(6,15-16,19,21), 
one controlled clinical trial (10%) with a moderate level of 
evidence(20), four quasi-experimental studies (40%), being 
two with low and two very low levels of evidence(5,17-18,22). 
Chart 3 shows the detail of the scores of the studies included 
in the review, according to the GRADE system(14).
Author/
year/place 
of study
Type of 
study Goal Sample Results
Group 3 – Admitted and non-admitted patients (inpatients/outpatients) in palliative care with advanced/terminal disease
A8
Chochinov 
et al., 
2005 – 
Canada(5)
Quasi-
experimental 
Study
Establish the viability 
of DT;
Determine its impact 
on measures of 
psychological and 
existential suffering.
n = 100 terminal 
cancer patients with life 
expectancy ≤ 6 months; 
(97% cancer and 3% 
non-malignant terminal 
conditions).
DT had good satisfaction rates, utility, increasing 
sense of dignity (p = 0.085), purpose, meaning and 
will to live, improved self-reported depressing mood 
(p = 0.05), suffering (p = 0.023) and quality of life 
(p = 0.049). Reported that the DT helped them or 
would help the families.
A9
Chochinov 
et al., 
2011 – 
Canada(21)
Randomized 
Clinical Trial
Compare DT with 
palliative care and 
patient-centered care 
standards regarding 
the dimensions of 
distress (depression 
and suffering), quality 
of life and dignity.
n = 326 patients in 
palliative care with 
life expectancy ≤ 6 
months, submitted to 
DT (n = 108), Patient-
Centered Care
(n = 107) and Palliative 
Care
(n = 111); (95.8% 
neoplasia and 4.3% 
non-malignant terminal 
conditions).
Patients who received DT reported better indices 
in: utility (p<0.001), quality of life (p<0.001), 
sense of dignity (p = 0.002), satisfaction (p<0.001), 
family assessment (p<0.001). Reported that the DT 
would help them or their families (p<0.001). There 
were also improvements in spiritual well-being 
(p = 0.006), a decrease in sadness or depression 
(p = 0.009). Better end-of-life quality experience. 
The ability to decrease depression, the wish for 
death or suicide was not proven.
A10
Houmann 
et al., 
2014 – 
Denmark(22)
Quasi-
experimental 
Study
Evaluate and explore 
the effectiveness of 
Dignity Therapy (DT) 
for patients with 
incurable cancer.
n = 80 patients with 
incurable cancer; 100% 
cancer with average 
survival of 4 months.
DT was considered: satisfactory and having useful 
potential to help for the family (73-89%), with an 
increase in the sense of dignity, purpose and the 
will to live (47-56%), making life more meaningful 
with reduction in pain and improvement of family 
assessment (25 to 43%). At first there was an 
increase in depression score and a decreased overall 
quality of life; in the second evaluation there was an 
increase in the sense of dignity and it reduced the 
feeling of being a burden.
...continuation
Chart 3 – Level of study evidence, according to the GRADE system(22) – São Paulo, 2015.
Author/Year Study design Reducing factors Increasing factors Level of evidence
I II III IV V VI VII VIII
Julião et al., 2013(6) (A1) CRCT a / / / -1 / / / / Moderate3
Julião et al., 2014(15) (A2) CRCT a / / / -1 / / / / Moderate3
Hall et al., 2011(16) (A3) CRCT a / / / / / / / / High4
Johns et al., 2013(17) (A4) QES c / / / / -1 / / / Very low1
Vergo et al., 2014(18) (A5) QES c / / / / -1 / / / Very low1
Rudilla et al., 2014(19) (A6) CRCT a -1 / / / -1 +1 / / Moderate3
Rudilla et al., 2015(20) (A7) CCT b -1 / / / / / / / Moderate3
Chochinov et al., 2005(5) (A8) QES c / / / / / / / / Low2
Chochinov et al., 2011(21) (A9) CRCT a / / / / / / / / High4
Houmann et al., 2014(22) (A10) QES c / / / / / / / / Low2
a Controlled Randomized Clinical Trial (CRCT) / b Controlled Clinical Trial (CCT) / c Quasi-Experimental Study (QES).
I – Risk of bias; II – Inconsistency; III – Indirect Evidence; IV – Imprecision; V – Publication Bias; VI – Effect size; VII – Dose-response gradient; VIII – Possible residual 
confusion.
* The bars represent that in the given aspect the study did not obtain a reduction or increase in scores.
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Group 1 – patients of palliative care with 
advanced/terminal disease in a hospitalization unit
Two randomized controlled trials with a moderate level 
of evidence were included in this group. The patients’ profile 
in these studies was: terminal patients with life expectancy ≤ 
6 months, mostly including oncological diseases of diverse 
origins and non-oncological diseases (amyotrophic lateral 
sclerosis and trigeminal neuralgia in both). The patients were 
cared for at a hospice units specialized in palliative care in 
both studies; they were allocated to two groups with one 
being DT, and the other where patients received standard 
palliative care therapy in which the institution’s conventional 
palliative care was administered by a multiprofessional spe-
cialized team(6,15).
In study A1, the patients were evaluated before the inter-
vention, presenting high rates of depression and anxiety. The 
results were statistically significant for depression (with the 
exception of the 30th day – p = 0.097) and for anxiety at all 
follow-up periods(6). In A2, patients also had higher rates of 
psychosocial distress in the initial evaluation, but the results 
were statistically significant at all follow-up periods for the 
two analyzed variables(15).
Group 2 – outpatients/patients in palliative care 
with advanced/terminal disease
In this group, five studies were included: a randomized 
controlled trial with a high level of evidence(16), a randomized 
controlled trial with a moderate level(16), a controlled clinical 
trial(20) with a moderate level of evidence, and two quasi-
experimental studies with very low levels of evidence(17-18). 
The profile of the patients included in these studies was: 
outpatients who attended the services for performing pro-
cedures and consultations and/or those followed by multi-
professional home visiting teams and/or nursing homes, with 
oncological and non-oncological diseases (unspecified)(16-20).
In A3, patients were allocated to the intervention group 
(DT) and to the control group, in which they received the 
institution’s standard palliative care therapy. All patients were 
older adults living in nursing homes with oncological and 
non-oncological diseases (unspecified). In the potential for 
efficacy (suffering related to dignity, loss of hope, depression, 
quality of life), there was only a small effect on reduction of 
depression (effect size = 0.05) and quality of life (effect size = 
0.02) in favor of DT, following 1 week post-intervention(16).
For outcome acceptability, a significant difference was 
observed in the comparison with control group for the vari-
ables making life more meaningful and family support both 
at 1 week follow-up (p = 0.02) and at 8 weeks post-inter-
vention (p = 0.01). The effect of DT on utility (effect size = 
0.55), increased sense of purpose (effect size = 0.53), will 
to live (effect size = 0.39) and decreased pain (effect size = 
0.34) was considered moderate at 8 weeks follow-up. The last 
outcome evaluated was viability, where the number of visits 
to complete the initial intervention (DT) was one visit (93%) 
and to complete the instrument was 1 to 5 visits on average(16).
In A4, the patients were women with metastatic cancer. 
DT was useful for themselves and their families in 75% 
of patients, increasing the meaning of life, sense of dignity 
and reduced suffering. There was 100% satisfaction, as the 
patients considered the generated document very useful. 
In comparing the measures performed before and after the 
intervention, however, there was an increase in levels of 
depression and anxiety(17).
In study A5, patients who were not hospitalized (outpa-
tients) and who went to services only to perform palliative 
chemotherapy were evaluated. For the outcome of viability, 
benefits of DT were observed for all variables (satisfaction, 
utility, increased sense of meaning, purpose, dignity and 
increased will to live). For the outcome of physical symp-
toms (pain, tiredness, nausea, drowsiness, appetite, dyspnea), 
only appetite improved after DT. Psychosocial symptoms 
(anxiety, depression, feeling of well-being, classification and 
satisfaction with quality of life and distress) were not affected 
by DT. The most satisfactory results were related to clinical 
outcomes, with increased acceptance of death one month 
after DT (57%) and improvement in the choice for treat-
ments that did not prolong life (58%)(18).
In study A6 with a quasi-experimental design, patients/
outpatients with neoplasia living in the home were evalu-
ated. Therapeutic counseling (TC) consisted of an approach 
developed to facilitate communication between the health 
professional and the patients, based on three pillars: technical 
knowledge, attitudes and relationship strategies (assertive 
communication, personal self-regulation skills and problem-
solving skills) with the goal of improving psychosocial symp-
toms(19). Both reduced suffering (DT p<0.001; TC p = 0.001), 
increased quality of life (DT p = 0.000; TC p = 0.009) and 
decreased existential distress (DT p = 0.003, TC p<0.001). 
Regarding the effect size of these variables, TC was superior 
for quality of life (DT = 1.69, TC = 3.47) and existential 
distress (DT = 1.94, TC = 3.34) and DT was higher for 
reducing suffering (DT = 2.74, TC = 2.50)(19).
In study A7, DT was also compared to TC in patients 
at home using a controlled clinical trial with a moderate 
level of evidence. In this case, a significant difference was 
observed between interventions only for the variable anxiety 
(p = 0.022), in favor of TC (effect = 0.65, considered moder-
ate). For the variables: peace of mind (DT p<0.001/effect = 
1.11; TC p<0.001/effect = 1.15), anxiety (DT p = 0.001/
effect = 0.58; TC p = 0.001/effect = 0.65), intrapersonal 
spirituality (DT p<0.001/effect = 1.12; TC p<0.001/effect = 
1.31) and transpersonal spirituality (DT p<0.001/effect = 
0.83; TC p<0.001/effect = 1.49), a significant difference with 
a large effect size was also observed, but in favor of TC(20).
Spirituality is defined as the human quest to transcend the 
self to find meaning and purpose through connection with 
others, with nature and/or “a Supreme Being,” which may or 
may not include religious institutions. Intrapersonal spiritual-
ity encompasses the elements of self-discovered spirituality, 
involving the search for meaning and purpose; interpersonal 
spirituality involves interpersonal relationships, through the 
relationship between the personal journey and other people’s 
journeys; and transpersonal spirituality is related to ecocon-
sciousness, meaning the connection of the personal journey 
with nature, insofar as all aspects of life are interconnected(23).
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Group 3 – admitted and non-admitted patients 
(inpatients/outpatients) in palliative care with an 
advanced/terminal disease
Three studies with quasi-experimental design and low 
level of evidence were included in this group. In these stud-
ies, the patients had a life expectancy of 4 to 6 months, most 
with advanced stage neoplasia of several origins and some 
patients with non-malignant terminal conditions (advanced 
stage of multiple organ failure)(5,21-22).
In study A8, the viability analysis showed that 91% were 
satisfied or very satisfied with DT, 86% considering it useful 
or very useful, 60% indicating increased sense of dignity, 68% 
increased sense of purpose, 67% increased sense of meaning, 
40% increased will to live and 81% reported that DT helped 
or would help their families. In the quantitative outcomes, 
post-intervention measures showed a significant reduction of 
suffering (p = 0.023), and improvement in depressing mood 
(p = 0.05); however, loss of hope, wishing for death, anxiety 
and suicide were not affected by DT. In the same study, the 
patients who reported the greatest psychosocial distress at 
the start of the study were those who reported the greatest 
benefits from therapy, and especially for: quality of life (p = 
0.049), level of dignity (p = 0.021) and lower risk of suicide 
(p = 0.012) measures, with all significantly related to utility 
and satisfaction with therapy(5).
In study A9, patients were randomly allocated into 
three different groups, with one for DT, one for standard 
palliative care therapy and one for patient-centered care. 
This study was considered as having a high level of evi-
dence for being a well-defined, randomized controlled 
trial. In standard palliative care therapy, patients received 
standard/conventional therapy from institutions where they 
were hospitalized or from multiprofessional home-visiting 
teams. Patient-centered care is a supportive psychothera-
peutic approach in which therapist-nurses guide patients to 
discussions focused on “here and now” issues; for example, 
participants answered questions about their illness associ-
ated with symptoms, and discussed what they were doing 
to solve their suffering. DT was superior to the two other 
approaches, showing significant utility (p<0.001), quality 
of life (p<0.001), sense of dignity (p = 0.002), satisfaction 
(p<0.001) and improvement of family appreciation in rela-
tion to the patient indices (p<0.001). In this study, patients 
also reported that DT helped or would significantly help 
their families (p<0.001) in comparison to the other groups. 
In the group that received DT, an improvement in spiritual 
well-being (p = 0.006) and improvement in the patients’ 
sadness or depression (p = 0.009) was also observed(21).
In study A10, patients with advanced neoplasia were 
evaluated. As it consisted of a quasi-experimental study, it 
was considered as having a low level of evidence. The average 
survival time of patients was about 4 months. The patients 
were submitted to DT and evaluated about 30 days after 
the initial measurements, and at a second moment of about 
60 days after the initial measurements. DT was considered 
useful, satisfactory and providing potential help for family 
members (73%); furthermore, DT increased sense of dignity, 
purpose and will to live, making life more meaningful for 
49% of those assessed. The 60-day post-assessment showed 
an increase in sense of dignity and a decrease in the feeling 
of being a burden to others, revealing that DT had prolonged 
effects for these variables. Initially, there was an increase in 
depression scores, but improvements were observed for this 
variable in the 60-day evaluation(22).
DISCUSSION
The studies included in this review evaluated physical, 
psychosocial and spiritual effects of dignity therapy, although 
not all articles evaluated all three aspects.
More severely afflicted patients at the start of the study 
may present impairment with the application of DT, since 
they can build a distorted view of themselves. However, the 
patients in A1 and A2 presented significant improvement in 
the variables of depression and anxiety, even in the presence 
of these conditions. In A1, the lack of prolonged effect of 
DT for depression following the 30th day may suggest an 
insufficient number of DT sessions(6,15).
In study A3, the DT-generated document had good 
acceptability, so much so that patients chose to turn it in 
before their own death. Also, the evaluation of those receiv-
ing the document was also satisfactory in that it provided 
better patient insight and pleasant discussions about the 
highlighted memories. In this study, the levels of distress 
measured before the intervention were relatively low and 
the patients reported a good quality of life; in that sense, 
there was little room for improvement, which may represent 
a limitation(16).
The A4 study sample was small (n = 10) and only four 
patients completed pre and post-intervention measures, 
associated with clinical deterioration throughout the follow-
up. Thus, the conclusions of this study should be observed 
cautiously, especially because it was classified with a very low 
level of evidence, with little confidence in the effect estimate. 
Thus, there is no way of stating whether the application 
of DT could increase levels of anxiety and depression in 
terminal patients(17).
In A5, DT showed good results mainly for improving the 
acceptance of death and end-of-life goals regarding treat-
ment and care; but because it was a quasi-experimental study, 
there was no control group for comparison. Therefore, it is 
not possible to determine if the improvement is related to 
the DT or the passage of time; in addition, it was a very 
small sample (only nine patients). Furthermore, many of the 
patients included in the study had never had a talk with the 
health team about prognosis, design, or therapeutic goals, 
and in providing that conversation, DT resulted in better 
acceptance of death and better end-of-life choices(21).
In A6 and A7, both therapies showed evidence that 
they can improve the well-being of patients in palliative 
care living in the home. Therapeutic counseling seems to 
exert more benefits than DT for the variables of anxiety, 
resilience, and depression. The patients submitted to DT 
presented a significant increase in depression after the 
intervention. The authors state that there are components 
of therapeutic counseling contained in dignity therapy, 
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which makes them similar, justifying the similarity of results 
between them and the lack of significant difference between 
the interventions(19-20).
Study A8 presented good results on the acceptance of 
DT by inpatients and outpatients. The authors emphasized 
the importance of psychotherapy that is highly referred to 
as a potential help for family members (81%), since feeling 
that DT would help family members significantly corre-
lated with increased sense of meaning (p<0.001), sense of 
purpose (p<0.001), accompanied by a decrease in suffering 
(p = 0.001). That is, the patients feeling that DT could help 
their families, even after their deaths, helped improve the 
end-of-life experience(5).
Study A9 showed that DT increased the quality of the 
end-of-life experience, with the ability to help the patients’ 
families. However, this study did not evaluate the measures 
of suffering and distress before the interventions were per-
formed. This initial evaluation could have improved the 
analysis of the differences between the three groups in the 
study, based on pre and post-intervention changes, allowing 
to hypothesize about the relationship between the initial 
level of anxiety in patients and the success of DT(21).
In study A10, the patients most severely affected by 
psychosocial suffering were prevented from entering the 
study due to the exclusion criteria, and therefore there is 
no way to know if the outcomes would be the same for this 
patient profile. In addition, patients chose to deliver the 
DT-generated document about 14 days after the interven-
tion, but when they had close relatives who were children, 
they had difficulty delivering and addressing the issue, so 
further studies should be conducted to determine the benefit 
of DT for patients who have children as close relatives(22).
In general, a limitation of applying DT in studies is the 
loss in follow-up of patients during the pre- and post-inter-
vention evaluations, since patients are in the terminal phase 
of life, and invariably their health conditions deteriorate, 
which makes it impossible for them to participate in the 
study due to lack of conditions or death.
Support for family members deserves special mention, 
since psychotherapies are focused on patients and their 
improvement outcomes, and most of the time they do not 
address family, friends and caregivers. The World Health 
Organization in its definition of palliative care advocates 
that all aspects of care should be addressed, including the 
psychosocial aspects. By improving family support, there 
is improvement in the end-of-life experience for patients, 
as evidenced by studies(7). Dignity therapy seems to exert 
a good influence on the family support variable, since this 
improvement was pointed out in five studies with one pre-
senting a moderate level of evidence and one a high level, 
meaning an estimate of approximate effect of the true 
effect(5,16-17,21-22). Thus, it may be the therapy of choice to 
improve these aspects.
In addition, DT appears to be well accepted by patients. 
It was identified as satisfactory in five studies(5,17-18,21-22), and 
useful in six studies, with levels of evidence ranging from 
very low to high(5,16-18,21-22). Increased dignity was noted in 
five studies(5,15,20-22), quality of life in four studies(15-17,19), and 
decreased suffering was observed in six studies(5,16-17,19-20). 
In other words, DT presented good levels of acceptance 
by inpatients and outpatients, both with oncological and 
non-oncological diseases and with reduced life expectancy. 
However, there is the need for further studies to evaluate the 
usefulness of therapy for non-malignant pathologies, since 
it was a minority in the studies evaluated. Although DT 
was designed with the intention of improving the patients’ 
spiritual issues, only two studies showed improvement in 
this aspect after DT, with a level of evidence of moderate 
to high(20-21).
Regarding the psychosocial distress variables, therapeutic 
counseling was superior to DT in the two studies comparing 
these variables(19-20). In two studies evaluating a reduction in 
depression and anxiety by DT, there was an improvement in 
scores, even for patients who were more severely distressed 
at the beginning of the study(6,16). In another three studies 
there was a decrease in depression after the intervention 
with DT(5,16,21). Although controversial, the application of 
DT appears to have had good effects on depression, with 
less impact on anxiety. However, larger impact studies and 
larger populations are needed to confirm the improvement or 
worsening of the psychosocial distress variables in monitor-
ing the effectiveness of DT.
Further studies are needed to prove the sustained ben-
efit of the therapy, as DT presented a sustained benefit in 
one study, however in another the improvement provided to 
depression symptoms was not sustained until the 30th day of 
intervention(6,16). None of the articles analyzed in this review 
were published in Brazil, indicating that this review may 
represent an initial step for the development of intervention 
studies in this area within Brazil.
Furthermore, none of the experimental articles analyzed 
were published by nurses, although these professionals have 
developed theoretical studies in this area. Considering the 
role of nurses in palliative care, we can note that it is a field 
with great potential for research development, especially 
intervention studies, which can bring advances to end-of-
life/hospice care.
This study has limitations, which should be pointed out. 
The inclusion of articles only in Portuguese, English and 
Spanish might have excluded important studies from other 
cultures/languages.
CONCLUSION
Dignity Therapy is a brief, individualized psychotherapy 
designed to address the psychosocial, spiritual, and physical 
issues of terminally ill patients. There is high and moder-
ate evidence supporting its application, with good effect 
estimates especially related to satisfaction, utility, increased 
dignity, meaning of life, sense of purpose and will to live, 
with a significant decrease in suffering. However, the per-
formance of dignity therapy for the variables of psychosocial 
distress (depression and anxiety) is still controversial, requir-
ing further evidence of greater impact. The effect of therapy 
on family support was highly satisfactory, demonstrating 
that DT can be useful for both patients and their families, 
improving the end-of-life experience. Physical symptoms do 
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not seem to be directly influenced by DT, although many 
symptoms are subjective and can be indirectly improved by 
the impact of DT on feelings and emotions. Spirituality also 
did not experience much impact of improvement reported 
by patients, and it should also be further evaluated in larger 
impact studies.
RESUMO
Objetivo: Analisar as evidências sobre os efeitos da terapia da dignidade para pacientes em fase terminal de vida. Método: Revisão 
sistemática da literatura realizada em seis bases de dados na estratégia de busca. Os critérios de inclusão foram estudos primários, 
excluindo-se revisões da literatura (sistemáticas ou não) e artigos conceituais. Resultados: Dez artigos foram analisados quanto ao 
método, aos resultados e nível de evidência. Nos estudos com maior nível de evidência, a terapia da dignidade melhorou o senso 
de significado, propósito, vontade de viver, utilidade, qualidade de vida, dignidade e apreciação familiar. Os efeitos não estão bem 
estabelecidos em relação à depressão, ansiedade, espiritualidade e aos sintomas físicos. Conclusão: Os estudos de nível de evidência 
de moderado a alto demonstraram aumento do senso de dignidade, vontade de viver e senso de propósito. Mais estudos devem ser 
desenvolvidos para ampliar o conhecimento sobre a terapia da dignidade.
DESCRITORES
Cuidados Paliativos; Doente Terminal; Psicoterapia Breve; Qualidade de Vida; Enfermagem Holística; Revisão.
RESUMEN
Objetivo: Analizar las evidencias acerca de los efectos de la terapia dignidad para pacientes en fase terminal de vida. Método: Revisión 
sistemática de la literatura llevada a cabo en seis bases de datos en la estrategia de búsqueda. Los criterios de inclusión fueron estudios 
primarios, excluyéndose las revisiones de literatura (sistemáticas o no) y los artículos conceptuales. Resultados: Diez artículos fueron 
analizados en cuanto al método, los resultados y el nivel de evidencia. En los estudios con mayor nivel de evidencia, la terapida de la 
dignidad mejoró el sentido de significado, propósito, ganas de vivir, utilidad, calidad de vida, dignidad y estimación familiar. Los efectos 
no están bien planteados con respecto a la depresión, ansiedad, espiritualidad y los síntomas físicos. Conclusión: Los estudios de nivel 
de evidencia de moderado a alto demostraron incremento del sentido de dignidad, ganas de vivir y sentido de propósito. Se deben 
desarrollar más estudios a fin de ampliar el conocimiento acerca de la terapia de la dignidad.
DESCRIPTORES
Cuidados Paliativos; Enfermo Terminal; Psicoterapia Breve; Calidad de Vida; Enfermería Holística; Revisión.
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